Peripheral Neuropathy Trial, Recruiting NCT07046767 Sponsor: Capsicure, LLC Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07046767
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 or older, of any gender
  • People who have a venous leg ulcer or diabetic foot ulcer that has not been healing for more than 4 weeks, and where the wound has reduced in size by less than 50% over the last 4 weeks
  • People whose wound measures between 2 cm² and 25 cm² in size
  • If a person has more than one wound that meets the criteria, the largest wound will be the one studied
  • People who are able and willing to follow the study requirements
  • People who have signed a consent form agreeing to take part

Who may not be able to join:

  • People who are unable or unwilling to follow the study schedule and requirements
  • People who are pregnant
  • People who are able to become pregnant and are not using appropriate contraception
  • People who are currently breastfeeding
  • People whose wound has been treated with engineered tissue or scaffold materials within the 30 days before the first treatment visit
  • People whose wound has already shown strong signs of improvement — meaning a 50% or more reduction in wound size in the four weeks before enrolment
  • People who have other health conditions that, in the opinion of the study doctor, could affect their safety during the trial
  • People who have a known reason they cannot receive amniotic tissue grafts (confirm with trial site)
  • People whose wound shows signs of active infection that requires treatment with antiseptics or antibiotics

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Windy Cole, DPM, Capsicure, LLC

Phone: 512-571-2966

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Capsicure, LLC
Registry
ClinicalTrials.gov
Start date
1 October 2025
Est. completion
20 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Wound Closure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov